Bond Screener
Daiichi Sankyo
LEI 353800XGIU2IHQGC9504
Organization name
Daiichi Sankyo Company, Limited
Country name
Japan
Country of registration
Japan
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
620 mln USD
Upgrade to Premium features
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get access
-
Full access to the largest bond database
Bond parameters,
prospectuses -
Seamless
Data exportAnalyze the data in the most efficient way
-
Bond pricing
Current & historical quotes from 400+ stock exchanges & OTC market
-
Smart risk assessment
Credit ratings, financial reports
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Daiichi Sankyo Company, Limited (第一三共株式会社 Daiichi Sankyō Kabushiki-kaisha?) is a global pharmaceutical company and the second largest pharmaceutical company in Japan. It achieved JPY 1,148.2 billion in revenue in 2013. The company owns the American biotechnology company Plexxikon, the German biotechnology company U3 Pharma and recently sold Ranbaxy Laboratories in India. Daiichi Sankyo Co., Ltd. is the producer of Benicar (Olmesartan), an angiotensin II receptor antagonist and top selling drug in the U.S. Global sales of Olmesartan in 2013 were 300.2 billion yen.
|
General information
-
Organization nameDaiichi Sankyo Company, Limited
-
Organization statusOperating organization
-
Address3-5-1, Nihonbashi-honcho Chuo-ku Tokyo, Japan, 103-8426
-
Site
News
| 20/08/2025 | Upcoming Issue: Daiichi Sankyo 1Y |
| 20/08/2025 | Upcoming Issue: Daiichi Sankyo 7Y |
| 20/08/2025 | Upcoming Issue: Daiichi Sankyo 5Y |
| 20/08/2025 | Upcoming Issue: Daiichi Sankyo 3Y |
| 31/01/2025 | Daiichi Sankyo's Nine-Month Profit Jumps 28% |
Stocks
General information
-
Organization nameDaiichi Sankyo Company, Limited
-
Organization statusOperating organization
-
Address3-5-1, Nihonbashi-honcho Chuo-ku Tokyo, Japan, 103-8426
-
Site
Codes
-
LEI353800XGIU2IHQGC9504
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
NACE*** ***
-
NAICS*** ***
-
CIK0001340156
